Efficacy and safety of tezepelumab in Japanese patients with chronic rhinosinusitis with nasal polyps: A subpopulation analysis of the randomized WAYPOINT study
Efficacy and safety of tezepelumab in Japanese patients with chronic rhinosinusitis with nasal polyps: A subpopulation analysis of the randomized WAYPOINT study. // Auris Nasus Larynx. – URL: https://www.sciencedirect.com/science/article/pii/S038581462600132X?dgcid=rss_sd_all
Efficacy and safety of tezepelumab in Japanese patients with chronic rhinosinusitis with nasal polyps: A subpopulation analysis of the randomized WAYPOINT study. Auris Nasus Larynx. https://www.sciencedirect.com/science/article/pii/S038581462600132X?dgcid=rss_sd_all
“Efficacy and safety of tezepelumab in Japanese patients with chronic rhinosinusitis with nasal polyps: A subpopulation analysis of the randomized WAYPOINT study.” Auris Nasus Larynx.
@article{article37023,
title = {Efficacy and safety of tezepelumab in Japanese patients with chronic rhinosinusitis with nasal polyps: A subpopulation analysis of the randomized WAYPOINT study},
journal = {Auris Nasus Larynx},
url = {https://www.sciencedirect.com/science/article/pii/S038581462600132X?dgcid=rss_sd_all}
}